{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:12:40Z","timestamp":1789081960547,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing-Tianjin-Hebei Basic Research Cooperation Special Projects","award":["23JCZXJC00090\/J230003"],"award-info":[{"award-number":["23JCZXJC00090\/J230003"]}]},{"name":"Tianjin Key Project of Health Science and Technology","award":["TJWJ2021ZD008"],"award-info":[{"award-number":["TJWJ2021ZD008"]}]},{"name":"Tianjin key Project of Municipal Education Commission Scientific Research Plan","award":["2024ZD051"],"award-info":[{"award-number":["2024ZD051"]}]},{"name":"Funded by Tianjin Key Medical Discipline Construction Project","award":["TJYXZDXK-3-002A"],"award-info":[{"award-number":["TJYXZDXK-3-002A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58241-3","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T09:44:32Z","timestamp":1782035072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ARL13B is regulated by the ERK\/P90 pathway and mediates TMZ resistance in glioblastoma via microvesicles"],"prefix":"10.1038","volume":"16","author":[{"given":"Haichao","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"issue":"3","key":"58241_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/pr.117.014944","volume":"70","author":"A Shergalis","year":"2018","unstructured":"Shergalis, A., Bankhead, A. 3rd, Luesakul, U., Muangsin, N. & Neamati, N. Current challenges and opportunities in treating glioblastoma. Pharmacol. Rev. 70 (3), 412\u2013445. https:\/\/doi.org\/10.1124\/pr.117.014944 (2018).","journal-title":"Pharmacol. Rev."},{"issue":"Supplement_6","key":"58241_CR2","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","volume":"26","author":"M Price","year":"2024","unstructured":"Price, M. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2017\u20132021. Neuro Oncol. 26 (Supplement_6), vi1\u2013vi85. https:\/\/doi.org\/10.1093\/neuonc\/noae145 (2024).","journal-title":"Neuro Oncol."},{"issue":"2","key":"58241_CR3","doi-asserted-by":"publisher","first-page":"188616","DOI":"10.1016\/j.bbcan.2021.188616","volume":"1876","author":"MS Tomar","year":"2021","unstructured":"Tomar, M. S., Kumar, A., Srivastava, C. & Shrivastava, A. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim. Biophys. Acta Rev. Cancer. 1876 (2), 188616. (2021). https:\/\/doi.org\/10.1016\/j.bbcan.2021.188616 (2021).\u00a0","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"58241_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","volume":"3","author":"SY Lee","year":"2016","unstructured":"Lee, S. Y. Temozolomide resistance in glioblastoma multiforme. Genes Dis. 3 (3), 198\u2013210 (2016). https:\/\/doi.org\/10.1016\/j.gendis.2016.04.007 (2016).","journal-title":"Genes Dis."},{"issue":"2","key":"58241_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen, D. K. et al. Reassessment Exosome Composition Cell. 177(2), 428\u2013445e18. https:\/\/doi.org\/10.1016\/j.cell.2019.02.029 (2019).","journal-title":"Reassessment Exosome Composition Cell."},{"issue":"34","key":"58241_CR6","doi-asserted-by":"publisher","first-page":"e2201609","DOI":"10.1002\/advs.202201609","volume":"9","author":"Q Yang","year":"2022","unstructured":"Yang, Q. et al. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Adv. Sci. (Weinh). 9 (34), e2201609. (2022). https:\/\/doi.org\/10.1002\/advs.202201609 (2022).\u00a0","journal-title":"Adv. Sci. (Weinh)"},{"key":"58241_CR7","doi-asserted-by":"publisher","first-page":"101167","DOI":"10.1016\/j.mam.2022.101167","volume":"91","author":"MN Russo","year":"2023","unstructured":"Russo, M. N., Whaley, L. A., Norton, E. S., Zarco, N. & Guerrero-C\u00e1zares, H. Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective. Mol. Aspects Med. 91, 101167. https:\/\/doi.org\/10.1016\/j.mam.2022.101167 (2023).\u00a0","journal-title":"Mol. Aspects Med."},{"key":"58241_CR8","doi-asserted-by":"publisher","unstructured":"Caspary, T., Larkins, C. E. & Anderson, K. V. The graded response to Sonic Hedgehog depends on cilia architecture. Dev Cell. 12(5), 767\u201378. https:\/\/doi.org\/10.1016\/j.devcel.2007.03.004 (2007).","DOI":"10.1016\/j.devcel.2007.03.004"},{"issue":"2","key":"58241_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ajhg.2008.06.023","volume":"83","author":"V Cantagrel","year":"2008","unstructured":"Cantagrel, V. et al. Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome. Am. J. Hum. Genet. 83 (2), 170\u2013179 (2008). https:\/\/doi.org\/10.1016\/j.ajhg.2008.06.023 (2008).\u00a0","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"58241_CR10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/cancers11101461","volume":"11","author":"C Casalou","year":"2019","unstructured":"Casalou, C. et al. Arl13b regulates breast cancer cell migration and invasion by controlling integrin-mediated signaling. Cancers (Basel). 11 (10), 1461 (2019). https:\/\/doi.org\/10.3390\/cancers11101461 (2019).\u00a0","journal-title":"Cancers (Basel)"},{"key":"58241_CR11","doi-asserted-by":"publisher","unstructured":"Shao, J. et al. Arl13b promotes gastric tumorigenesis by regulating smo trafficking and activation of the hedgehog signaling pathway. Cancer Res. 77(15), 4000\u20134013. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2461IF (2017).","DOI":"10.1158\/0008-5472.CAN-16-2461IF"},{"issue":"5","key":"58241_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/neuonc\/noac245","volume":"25","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling. Neuro Oncol. 25 (5), 871\u2013885. (2023). https:\/\/doi.org\/10.1093\/neuonc\/noac245 (2023).\u00a0","journal-title":"Neuro Oncol."},{"issue":"4","key":"58241_CR13","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/brain\/awab020","volume":"144","author":"JM Shireman","year":"2021","unstructured":"Shireman, J. M. et al. De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain 144 (4), 1230\u20131246 (2021). https:\/\/doi.org\/10.1093\/brain\/awab020 (2021).\u00a0","journal-title":"Brain"},{"issue":"7","key":"58241_CR14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3390\/cancers13071644","volume":"13","author":"P Shi","year":"2021","unstructured":"Shi, P. et al. HDAC6 Signaling at primary cilia promotes proliferation and restricts differentiation of glioma cells. Cancers (Basel). 13 (7), 1644. (2021). https:\/\/doi.org\/10.3390\/cancers13071644 (2021).\u00a0","journal-title":"Cancers (Basel)"},{"issue":"52","key":"58241_CR15","doi-asserted-by":"publisher","first-page":"21354","DOI":"10.1073\/pnas.1218272110","volume":"109","author":"DC Barral","year":"2012","unstructured":"Barral, D. C. et al. Arl13b regulates endocytic recycling traffic. Proc. Natl. Acad. Sci. U S A. 109 (52), 21354\u201321359. (2012). E https:\/\/doi.org\/10.1073\/pnas.1218272110 (2012).\u00a0","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"12","key":"58241_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41419-019-2108-x","volume":"10","author":"K Zhao","year":"2019","unstructured":"Zhao, K. et al. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGF\u03b2 pathway-dependent manner. Cell. Death Dis. 10 (12), 877. (2019). https:\/\/doi.org\/10.1038\/s41419-019-2108-x (2019).\u00a0","journal-title":"Cell. Death Dis."},{"issue":"2","key":"58241_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5966\/sctm.2013-0132","volume":"3","author":"SM Kim","year":"2014","unstructured":"Kim, S. M. et al. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Stem Cells Transl. Med. 3 (2), 172\u2013182. (2014). https:\/\/doi.org\/10.5966\/sctm.2013-0132 (2014).\u00a0","journal-title":"Stem Cells Transl Med."},{"issue":"1","key":"58241_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2015.11.011","volume":"29","author":"TK Hayes","year":"2016","unstructured":"Hayes, T. K. et al. Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression. Cancer Cell. 29 (1), 75\u201389 (2016).","journal-title":"Cancer Cell."},{"key":"58241_CR19","doi-asserted-by":"publisher","unstructured":"Weller, M. et al. European Association for Neuro-Oncology (EANO) Task Force on Gliomas. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol. 18(6), e315-e329. 10.1016\/S1470-2045(17)30194-8. Epub 2017 May 5. Erratum in: Lancet Oncol. 2017;18(11):e642. https:\/\/doi.org\/10.1016\/S1470-2045(17)30194-8 Epub 2017 May 5. Erratum in: Lancet Oncol. 2017 Nov;18(11):e642. doi: 10.1016\/S1470-2045(17)30795-7\u00a0(2017).","DOI":"10.1016\/S1470-2045(17)30194-8"},{"issue":"1","key":"58241_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbcan.2011.12.004","volume":"1826","author":"JR Silber","year":"2012","unstructured":"Silber, J. R., Bobola, M. S., Blank, A. & Chamberlain, M. C. O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems. Biochim. Biophys. Acta. 1826 (1), 71\u201382. (2012). https:\/\/doi.org\/10.1016\/j.bbcan.2011.12.004 (2012).\u00a0","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"58241_CR21","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1158\/0008-5472.CAN-10-3213","volume":"71","author":"EM Goellner","year":"2011","unstructured":"Goellner, E. M. et al. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. Cancer Res. 71 (6), 2308\u20132317. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3213 (2011).\u00a0","journal-title":"Cancer Res."},{"issue":"15","key":"58241_CR22","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.18632\/oncotarget.2225","volume":"5","author":"AA Patil","year":"2014","unstructured":"Patil, A. A. et al. FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents. Oncotarget 5 (15), 6414\u20136424. https:\/\/doi.org\/10.18632\/oncotarget.2225 (2014).\u00a0","journal-title":"Oncotarget"},{"issue":"1","key":"58241_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.20517\/cdr.2020.79","volume":"4","author":"N Singh","year":"2021","unstructured":"Singh, N., Miner, A., Hennis, L. & Mittal, S. Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. Cancer Drug Resist. 4 (1), 17\u201343 (2021). https:\/\/doi.org\/10.20517\/cdr.2020.79 (2021).","journal-title":"Cancer Drug Resist."},{"issue":"1","key":"58241_CR24","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1038\/s41598-018-21710-5","volume":"8","author":"SA Mirzaei","year":"2018","unstructured":"Mirzaei, S. A. et al. Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells. Sci. Rep. 8 (1), 3446. https:\/\/doi.org\/10.1038\/s41598-018-21710-5 (2018).","journal-title":"Sci. Rep."},{"key":"58241_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12935-020-01515-1","volume":"20","author":"WC Lu","year":"2020","unstructured":"Lu, W. C. et al. Identification of potential biomarkers and candidate small molecule drugs in glioblastoma. Cancer Cell. Int. 20, 419. (2020). https:\/\/doi.org\/10.1186\/s12935-020-01515-1 (2020).","journal-title":"Cancer Cell. Int."},{"issue":"45","key":"58241_CR26","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1038\/onc.2011.636","volume":"31","author":"B Li","year":"2012","unstructured":"Li, B., Antonyak, M. A., Zhang, J. & Cerione, R. A. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 31 (45), 4740\u20134749. https:\/\/doi.org\/10.1038\/onc.2011.636 (2012).\u00a0","journal-title":"Oncogene"},{"issue":"1","key":"58241_CR27","doi-asserted-by":"publisher","first-page":"1722433","DOI":"10.1080\/20013078.2020.1722433","volume":"9","author":"R Crescitelli","year":"2020","unstructured":"Crescitelli, R. et al. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation. J. Extracell. Vesicles. 9 (1), 1722433 (2020).","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"58241_CR28","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1038\/s41467-023-41663-2","volume":"14","author":"J Yin","year":"2023","unstructured":"Yin, J. et al. Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas. Nat. Commun. 14 (1), 5913. (2023). https:\/\/doi.org\/10.1038\/s41467-023-41663-2 (2023).","journal-title":"Nat. Commun."},{"issue":"2","key":"58241_CR29","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1074\/jbc.M114.590943","volume":"290","author":"H Zhang","year":"2015","unstructured":"Zhang, H., Chi, Y., Gao, K., Zhang, X. & Yao, J. p53 protein-mediated up-regulation of MAP kinase phosphatase 3 (MKP-3) contributes to the establishment of the cellular senescent phenotype through dephosphorylation of extracellular signal-regulated kinase 1\/2 (ERK1\/2). J. Biol. Chem. 290 (2), 1129\u20131140 (2015).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"58241_CR30","doi-asserted-by":"publisher","first-page":"e38706","DOI":"10.1371\/journal.pone.0038706","volume":"7","author":"CJ Lin","year":"2012","unstructured":"Lin, C. J. et al. Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS One. 7 (6), e38706 (2012).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58241-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:01:25Z","timestamp":1789081285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58241-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58241"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58241-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental protocols were approved by the Ethics Review Committee of Tianjin Huanhu Hospital (Approval Number: 202506181434000373866).","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28405"}}